Corporate News 18-Oct-23
USFDA classifies inspection of Biocon Biologic's Malaysian unit as 'OAI'
Biocon announced that Biocon Sdn Bhd., a step-down subsidiary of Biocon Biologics has received a communication from the U.S. Food and Drug Administration (FDA) pursuant to its July 2023 cGMP inspection at its insulins manufacturing facility at Johor, Malaysia. The FDA has determined the inspection classification as “OAI” (Official Action Indicated). The OAI status may cause delay and/or withholding of pending product approvals or supplements from the facility.
Previous News
Sensex spurts 714 pts; auto shares in demand
( Market Commentary - Mid-Session 09-Aug-24 10:32 )
Biocon arm gets USFDA nod for chronic heart failure drug
( Hot Pursuit - 02-Sep-24 08:59 )
Biocon issues corporate guarantee of $20 mn for Biocon Generics
( Corporate News - 24-Feb-24 12:47 )
Biocon PAT slides 57% to Rs 136 crore in Q4 FY24
( Hot Pursuit - 17-May-24 10:37 )
Biocon Q1 PAT soars YoY to Rs 660 cr in FY25
( Hot Pursuit - 09-Aug-24 12:19 )
Biocon consolidated net profit declines 56.74% in the March 2024 quarter
( Results - Announcements 16-May-24 18:25 )
Biocon gets US FDA approval for market generic version of anti-cancer drug
( Hot Pursuit - 07-Feb-24 09:35 )
Biocon Biologics partners with Sandoz AG
( Corporate News - 09-Feb-24 09:15 )
Biocon receives Complete Response Letter for Biologics License Application
( Corporate News - 09-Feb-24 09:11 )
Biocon partners with Juno Pharmaceuticals
( Corporate News - 06-Oct-23 18:48 )
Biocon Ltd soars 3.74%, rises for third straight session
( Hot Pursuit - 02-Jan-24 13:05 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
